SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-110287
Filing Date
2021-04-08
Accepted
2021-04-08 16:43:57
Documents
18
Period of Report
2021-04-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d123419d8k.htm   iXBRL 8-K 38267
2 EX-1.1 d123419dex11.htm EX-1.1 153234
3 EX-3.1 d123419dex31.htm EX-3.1 81287
4 EX-4.1 d123419dex41.htm EX-4.1 220306
5 EX-5.1 d123419dex51.htm EX-5.1 11874
10 GRAPHIC g123419dsp4.jpg GRAPHIC 8598
  Complete submission text file 0001193125-21-110287.txt   795375

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA tmb-20210405.xsd EX-101.SCH 4142
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tmb-20210405_def.xml EX-101.DEF 14253
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE tmb-20210405_lab.xml EX-101.LAB 23583
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tmb-20210405_pre.xml EX-101.PRE 15286
11 EXTRACTED XBRL INSTANCE DOCUMENT d123419d8k_htm.xml XML 5638
Mailing Address 2200 POWELL STREET SUITE 310 EMERYVILLE CA 94608
Business Address 2200 POWELL STREET SUITE 310 EMERYVILLE CA 94608 510-204-7239
XOMA Corp (Filer) CIK: 0000791908 (see all company filings)

IRS No.: 522154066 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39801 | Film No.: 21815323
SIC: 2834 Pharmaceutical Preparations